Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales
Statistical Methods in Medical Research · 2025
DOI: 10.1177/09622802251338387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2025. Verfasst von Emma Davies Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Endpoint Determination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Cluster randomized trials commonly employ multiple endpoints. When a single summary of treatment effects across endpoints is of primary interest, global methods represent a common analysis strategy. However, specification of the required joint distribution is non-trivial, particularly when the endpoints have different scales. We develop rank-based interval estimators for a global treatment effect referred to here as the “global win probability, or the mean of multiple Wilcoxon Mann–Whitney probabilities, and interpreted as the probability that a treatment individual responds better than a control individual on average. Using endpoint-specific ranks among the combined sample and within each arm, each individual-level observation is converted to a “win fraction” which quantifies the proportion of wins experienced over every observation in the comparison arm. An individual’s multiple observations are then replaced with a single “global win fraction” by averaging win fractions across endpoints. A linear mixed model is applied directly to the global win fractions to obtain point, variance, and interval estimates adjusted for clustering. Simulation demonstrates our approach performs well concerning confidence interval coverage and type I error, and methods are easily implemented using standard software. A case study using public data is provided with corresponding R and SAS code.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
- Alimentiv Inc., London, ON, Canada.
- Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.
- Robarts Research Institute, Schulich School of Medicine & Dentistry, London, ON, Canada.
ORCID-Profile: Emma Davies Smith
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Davies Smith, E., Jairath, V., & Zou, G. (2025). Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802251338387
Vancouver
Davies Smith E, Jairath V, Zou G. Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales. Statistical Methods in Medical Research. 2025. doi:10.1177/09622802251338387
BibTeX
@article{DaviesSmith2025,
author = {Davies Smith, Emma and Jairath, Vipul and Zou, Guangyong},
title = {Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales},
journal = {Statistical Methods in Medical Research},
year = {2025},
doi = {10.1177/09622802251338387}
}
EUVIMED